After an early focus on AstraZeneca and months of turmoil, the European Union is pivoting away from the company’s vaccine. It has reached agreement for a faster rollout of the Pfizer-BioNTech shot. Source: New York Times
0
0
Happy
0 %
Sad
0 %
Excited
0 %
Sleppy
0 %
Angry
0 %
Surprise
0 %
